- Home
- MNR vs BCRX Comparison
MNR vs BCRX Comparison
Compare MNR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNR
- BCRX
- Stock Information
- Founded
- MNR 2017
- BCRX 1986
- Country
- MNR United States
- BCRX United States
- Employees
- MNR N/A
- BCRX N/A
- Industry
- MNR
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNR
- BCRX Health Care
- Exchange
- MNR Nasdaq
- BCRX Nasdaq
- Market Cap
- MNR 1.9B
- BCRX 1.9B
- IPO Year
- MNR 2023
- BCRX 1994
- Fundamental
- Price
- MNR $16.03
- BCRX $9.21
- Analyst Decision
- MNR Strong Buy
- BCRX Buy
- Analyst Count
- MNR 3
- BCRX 6
- Target Price
- MNR $23.00
- BCRX $15.50
- AVG Volume (30 Days)
- MNR 435.7K
- BCRX 3.1M
- Earning Date
- MNR 03-31-2025
- BCRX 02-24-2025
- Dividend Yield
- MNR 17.17%
- BCRX N/A
- EPS Growth
- MNR N/A
- BCRX N/A
- EPS
- MNR N/A
- BCRX N/A
- Revenue
- MNR $873,766,000.00
- BCRX $412,579,000.00
- Revenue This Year
- MNR $48.45
- BCRX $38.44
- Revenue Next Year
- MNR $4.57
- BCRX $21.23
- P/E Ratio
- MNR N/A
- BCRX N/A
- Revenue Growth
- MNR 21.20
- BCRX 29.92
- 52 Week Low
- MNR $14.46
- BCRX $4.03
- 52 Week High
- MNR $21.19
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- MNR 38.42
- BCRX 65.48
- Support Level
- MNR $15.56
- BCRX $8.63
- Resistance Level
- MNR $16.65
- BCRX $9.00
- Average True Range (ATR)
- MNR 0.44
- BCRX 0.36
- MACD
- MNR -0.09
- BCRX 0.07
- Stochastic Oscillator
- MNR 18.50
- BCRX 85.20
About MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company focused on the acquisition, development and production of oil, natural gas and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.